(02-17-2016, 10:07 AM)DividendGarden Wrote: Dr. Pepper Snapple (DPS) is one of my largest holdings, and I've had it for many years. This morning they reported earnings, but gave "weak" guidance for 2016, although it was still positive growth and I didn't view it as weak. Just wondering if anyone had thoughts. Bought back 3% of outstanding shares, margins expanded, lots of growth across the board. I still feel great about DPS and will continue to DRIP as I have for many years.
Dr Pepper Snapple (NYSE:DPS): Q4 EPS of $1.00 beats by $0.02.
Revenue of $1.55B (+2.6% Y/Y) beats by $20M.
FY2016 Guidance: Net sales: ~+1%; Core EPS: $4.20 to $4.30; Core tax rate: ~35.5%; Capex: ~3% of net sales.
http://seekingalpha.com/pr/16209956-dr-pepper-snapple-group-reports-fourth-quarter-full-year-2015-results
When I saw the price at $88 this morning I almost bought some. I was wanting the market to drop as the day went on and drag DPS to $86 or $87. Next time I looked it was already back over $90. Hopefully I will get my chance to buy this stock in the next couple of days.